Product identity & evidence
Start with what the label says — and what it cannot prove.
Dynamic scientific explanation
Dilution & concentration
How adding more or less liquid changes theoretical concentration.
Live comparison
What does this change mean?
The model assumes dissolved mass and negligible powder displacement. Actual final solution volume, solubility and formulation compatibility can differ.
Syringes & needle anatomy
Compare volume scales, needle thickness, length and dead space.
Conceptual cross-sections, not to scale. Actual internal diameter varies with needle wall design.
Dynamic equipment explanation
Measurement-error sensitivity
Explore how small volume-reading errors can affect a calculated mass.
This teaching example fixes the observed volume at 0.10 mL, solely to demonstrate measurement mathematics. It is not an injection-volume recommendation. Assume ± half a marked graduation as a simplified rounding error.
Dynamic measurement explanation
This is not a device-accuracy specification. Real uncertainty also includes parallax, device tolerances, technique, fluid retention and formulation variation.
Vial inventory vs. duration
Quantity remaining is not the same as product stability or safe storage life.
Allocation approach
Equal mathematical allocation
This does not suggest or justify using the entire vial or changing prescribed treatment. It is only an arithmetic illustration.
Enter weekly mass quantities only from an existing authorised clinical or trial protocol. This tool does not generate dose escalation, translate values into syringe markings, or recommend administration.
Remaining fraction by week
Inventory interpretation
Storage, stability & contamination
Explore the difference between a remaining supply and verified usable lifetime.
Enter only a validated, product-specific duration. Do not assume 28 days.
Dynamic storage and stability explanation
A generic 28-day multidose-vial rule does not demonstrate that an unapproved or reconstituted research product remains sterile or chemically stable for 28 days.
Clinical context & adverse effects
Show how formulation mathematics differs from pharmacology and patient safety.
Dynamic clinical context
Calculated concentrations do not predict patient response. Clinical effects depend on the actual molecule, exposure, health conditions, concomitant medicines and verified formulation quality.
Dynamic findings & learning priorities
Teaching alerts generated from the scenario. This is not a validated risk score.
Information entered in this simulator is stored only in this browser for convenience. Reset removes the saved scenario. No internet connection is required for the simulator itself.
References & scientific limits
- Therapeutic Goods Administration — counterfeit retatrutide safety alert (2026)
- US CDC — injection safety and multidose-vial practices
- DailyMed — bacteriostatic water for injection labelling
- Eli Lilly — retatrutide background and development
Sources provide educational context, not validation of a specific powder, reconstitution technique, injection device or vial expiry. This model uses label-based assumptions and simplified arithmetic, not validated pharmaceutical quality-control methods.